AbbVie shared a post on X:
“During EHA2026, we’re sharing more about the latest advancements in blood cancer research, including diffuse large B-cell lymphoma and follicular lymphoma. We are focused on our commitment to helping improve outcomes for people living with Blood Cancer.”
Other articles about AbbVie on OncoDaily.